Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus

Objective. Systemic lupus erythematosus (SLE) is treated with anti-inflammatory and immunosuppressive drugs and off-label biologics. Belimumab is the first biologic approved after 50 years as an add-on therapy for active disease. This paper summarizes a health technology assessment performed in Ital...

Descripción completa

Detalles Bibliográficos
Autores principales: Specchia, Maria Lucia, de Waure, Chiara, Gualano, Maria Rosaria, Doria, Andrea, Turchetti, Giuseppe, Pippo, Lara, Di Nardo, Francesco, Capizzi, Silvio, Cadeddu, Chiara, Kheiraoui, Flavia, Iaccarino, Luca, Pierotti, Francesca, Palla, Ilaria, Veneziano, Maria Assunta, Gliubizzi, Daniela, Sferrazza, Antonella, Nicolotti, Nicola, Porcasi, Rolando, La Torre, Giuseppe, Di Pietro, Maria Luisa, Ricciardi, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150460/
https://www.ncbi.nlm.nih.gov/pubmed/25243173
http://dx.doi.org/10.1155/2014/704207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150460/
https://www.ncbi.nlm.nih.gov/pubmed/25243173
http://dx.doi.org/10.1155/2014/704207

Ejemplares similares